Metabolic-only response assessment for omission of residual node radiation therapy (RNRT) for patients with classical Hodgkin lymphoma (cHL) and impact on event free (EFS) and overall survival (OS): A report from the Pediatric Hodgkin Consortium’s phase 2 study cHOD17 (NCT03755804).Jamie E. Flerlage, Jessi Rogers-Blake, Lindsay Wilemon et al.|Journal of Clinical Oncology|2025Cited by 0
32 | METABOLIC‐ONLY RESPONSE ASSESSMENT ALLOWS RADIATION OMISSION FOR MAJORITY WITH CLASSICAL HODGKIN LYMPHOMA AND MAINTAINS EXCELLENT OUTCOMES: A PHC PHASE 2 STUDY cHOD17Jamie E. Flerlage, Matthias J. Ehrhardt, Angela M. Feraco et al.|Hematological Oncology|2025Cited by 0
METABOLIC-ONLY RESPONSE ASSESSMENT ALLOWS FOR OMISSION OF RESIDUAL NODE RADIATION THERAPY (RNRT) FOR THE MAJORITY OF PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA (cHL) WHILE MAINTAINING EXCELLENT EVENT FREE (EFS) AND OVERALL SURVIVAL (OS): A REPORT FROM THE PEDIATRIC HODGKIN CONSORTIUM’S PHASE 2 STUDY cHOD17 (NCT03755804)Jamie E. Flerlage, Matthew J. Ehrhardt, Angela M. Feraco et al.|Leukemia Research|2025Cited by 0